Febuxostat Tablet
Product Images NDC 70771-1552

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Febuxostat (NDC 70771-1552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40 mg Label (2a9fa82f De69 4251 8560 5a59d41356b7 01)

40 mg Label (2a9fa82f De69 4251 8560 5a59d41356b7 01)
Label for Febuxostat Tablets 40 mg oral tablets, packaged in a container of 30 tablets by Zydus Lifesciences Limited. The label includes dispensing instructions for pharmacists, storage conditions, child-resistant packaging notice, and manufacturer information. Barcode and revision date (08/24) are also visible.*
FDA Label Image

80 mg Label (2a9fa82f De69 4251 8560 5a59d41356b7 02)

80 mg Label (2a9fa82f De69 4251 8560 5a59d41356b7 02)
Febuxostat Tablets 80 mg oral tablets label by Zydus Lifesciences Limited. The label indicates a package containing 30 tablets with dosage strength of 80 mg each. It includes dispensing instructions, storage conditions, child-resistant packaging information, and manufacturer details from Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.